- Home
- SMID vs RGC Comparison
SMID vs RGC Comparison
Compare SMID & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMID
- RGC
- Stock Information
- Founded
- SMID 1960
- RGC 2014
- Country
- SMID United States
- RGC Hong Kong
- Employees
- SMID N/A
- RGC N/A
- Industry
- SMID Building Materials
- RGC Medicinal Chemicals and Botanical Products
- Sector
- SMID Industrials
- RGC Health Care
- Exchange
- SMID Nasdaq
- RGC Nasdaq
- Market Cap
- SMID 157.4M
- RGC 38.6B
- IPO Year
- SMID 1995
- RGC 2021
- Fundamental
- Price
- SMID $37.91
- RGC $14.66
- Analyst Decision
- SMID
- RGC
- Analyst Count
- SMID 0
- RGC 0
- Target Price
- SMID N/A
- RGC N/A
- AVG Volume (30 Days)
- SMID 20.4K
- RGC 2.8M
- Earning Date
- SMID 07-10-2025
- RGC 06-30-2025
- Dividend Yield
- SMID N/A
- RGC N/A
- EPS Growth
- SMID 444.88
- RGC N/A
- EPS
- SMID 1.86
- RGC N/A
- Revenue
- SMID $84,450,000.00
- RGC N/A
- Revenue This Year
- SMID N/A
- RGC N/A
- Revenue Next Year
- SMID N/A
- RGC N/A
- P/E Ratio
- SMID $19.14
- RGC N/A
- Revenue Growth
- SMID 33.01
- RGC N/A
- 52 Week Low
- SMID $25.13
- RGC $0.08
- 52 Week High
- SMID $51.96
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- SMID 71.21
- RGC 45.32
- Support Level
- SMID $32.85
- RGC $9.39
- Resistance Level
- SMID $35.37
- RGC $30.00
- Average True Range (ATR)
- SMID 1.63
- RGC 6.44
- MACD
- SMID 0.51
- RGC -1.70
- Stochastic Oscillator
- SMID 82.07
- RGC 20.68
About SMID Smith-Midland Corporation
Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.